The Nordic Lymphoma Group (NLG) study in adult anaplastic large cell lymphoma

Francesco d’Amore, MD, PhD from Aarhus University, Aarhus, Denmark talks about the Nordic Lymphoma Group (NLG) study on the addition of etoposide to CHOP in adult anaplastic large cell lymphoma patients. Dr d’Amore discusses how the addition of etoposide improves the outcome of patients, as demonstrated by the Phase II clinical trial published in 2012 on the use of CHOEP bi-weekly followed by autologous transplant consolidation in young patients.
Recorded at the American Society of Hematology (ASH) 2015 Annual Meeting in Orlando, FL.

Share this video